NEW YORK, Nov 7 (Reuters) - Privately held Prometheus Laboratories Inc said on Wednesday it has agreed to acquire exclusive U.S. rights to GlaxoSmithKline's irritable bowel syndrome drug Lotronex.
Case Name: Prometheus Labs, Inc. v. Roxane Labs, Inc., Case Nos. 11-230 (FSH), 11-1241 (FSH), Unpublished (D.N.J. May 21, 2014) (Hochberg, J.) Drug Product and Patent ...
In an opinion handed down on March 20, 2012, the Supreme Court determined that patents covering thiopurine dosing tests covered unpatentable subject matter. The Court held that while the application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback